Accumulation of Boron in Human Malignant Glioma Cells in vitro is Cell Type Dependent

作者: Maria Dahlström , Jacek Capala , Peter Lindström , Åke Wasteson , Annelie Lindström

DOI: 10.1023/B:NEON.0000033489.54011.6B

关键词:

摘要: It has been shown that human malignant glioma tumours consist of several subpopulations tumour cells. Due to heterogeneity and different degrees vascularisation cell possess varying resistance chemo- or radiation therapy. Therefore, therapy is dependent on the ability specifically target a cell. Boron neutron capture (BNCT) bimodal method, in therapy, taking advantage stable isotope boron-10 neutrons. results disintegration products depositing large amounts energy within short length, approximately one diameter. Thereby, selective irradiation may be accomplished if sufficient amount boron accumulated hence cell-associated concentration critical importance. The accumulation boron, boronophenylalanine (BPA), was investigated two fibroblast line vitro. cells were incubated at low concentrations (0-5 microg B/ml). Oil filtration then used for separation extracellular boron. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) determination. Significant (P < 0.05) differences ratio (relation between concentration) lines found. Human fibroblasts, represent normal cells, showed growth-dependent uptake lower than Our findings indicate BPA concentration, incubation time should considered BNCT.

参考文章(20)
Pontén J, Westermark B, Properties of human malignant glioma cells in vitro. Medical biology. ,vol. 56, pp. 184- ,(1978)
R. Gahbauer, N. Gupta, T. Blue, J. Goodman, R. Barth, J. Grecula, A. H. Soloway, W. Sauerwein, A. Wambersie, Boron neutron capture therapy: principles and potential. Recent results in cancer research. ,vol. 150, pp. 183- 209 ,(1998) , 10.1007/978-3-642-78774-4_12
Samir C. Mehta, D. Robert Lu, Targeted drug delivery for boron neutron capture therapy Pharmaceutical Research. ,vol. 13, pp. 344- 351 ,(1996) , 10.1023/A:1016076022267
Manfred Papaspyrou, Hans-W. Müller-Gärtner, Ludwig E. Feinendegen, Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells. Cancer Research. ,vol. 54, pp. 6311- 6314 ,(1994)
Albert H. Soloway, Werner Tjarks, Beverly A. Barnum, Feng-Guang Rong, Rolf F. Barth, Iwona M. Codogni, J. Gerald Wilson, The Chemistry of Neutron Capture Therapy. Chemical Reviews. ,vol. 98, pp. 1515- 1562 ,(1998) , 10.1021/CR941195U
Jacek Capala, Michael S. Makar, Jeffrey A. Coderre, Accumulation of Boron in Malignant and Normal Cells Incubated In Vitro with Boronophenylalanine, Mercaptoborane or Boric Acid Radiation Research. ,vol. 146, pp. 554- 560 ,(1996) , 10.2307/3579556
Jacek Capala, Britta H.-Stenstam, Kurt Sköld, Per Munck af% Rosenschöld, Valerio Giusti, Charlotta Persson, Eva Wallin, Arne Brun, Lars Franzen, Jörgen Carlsson, Leif Salford, Crister Ceberg, Bertil Persson, Luigi Pellettieri, Roger Henriksson, Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden Journal of Neuro-oncology. ,vol. 62, pp. 135- 144 ,(2003) , 10.1023/A:1023230801571
H. Fukuda, J. Hiratsuka, C. Honda, T. Kobayashi, K. Yoshino, H. Karashima, J. Takahashi, Y. Abe, K. Kanda, M. Ichihashi, Y. Mishima, Boron Neutron Capture Therapy of Malignant Melanoma Using 10B-Paraboronophenylalanine with Special Reference to Evaluation of Radiation Dose and Damage to the Normal Skin Radiation Research. ,vol. 138, pp. 435- 442 ,(1994) , 10.2307/3578693
Jeffrey A. Coderre, Gerard M. Morris, The Radiation Biology of Boron Neutron Capture Therapy Radiation Research. ,vol. 151, pp. 1- 18 ,(1999) , 10.2307/3579742
Stefan Sjöberg, Jörgen Carlsson, Hadi Ghaneolhosseini, Lars Gedda, Torbjörn Hartman, Jonas Malmquist, Charlotta Naeslund, Pär Olsson, Werner Tjarks, Chemistry and biology of some low molecular weight boron compounds for Boron Neutron Capture Therapy Journal of Neuro-oncology. ,vol. 33, pp. 41- 52 ,(1997) , 10.1023/A:1005756929011